These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5000470)

  • 61. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 62. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
    Azuma I
    Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
    [No Abstract]   [Full Text] [Related]  

  • 63. Cross immunity between mycobacterial and Pseudomonas pseudomallei infections in mice.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1971 Apr; 103(4):569-71. PubMed ID: 4927632
    [No Abstract]   [Full Text] [Related]  

  • 64. The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.
    Prados-Rosales R; Carreño LJ; Weinrick B; Batista-Gonzalez A; Glatman-Freedman A; Xu J; Chan J; Jacobs WR; Porcelli SA; Casadevall A
    J Infect Dis; 2016 Aug; 214(3):426-37. PubMed ID: 27234419
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis.
    Janicki BW; Good RC; Minden P; Affronti LF; Hymes WF
    Am Rev Respir Dis; 1973 Mar; 107(3):359-66. PubMed ID: 4632222
    [No Abstract]   [Full Text] [Related]  

  • 67. Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis.
    Sugawara I; Li Z; Sun L; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Nov; 87(6):518-25. PubMed ID: 17720625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis.
    Palmer MV; Thacker TC; Waters WR
    Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection.
    Ryan AA; Spratt JM; Britton WJ; Triccas JA
    Infect Immun; 2007 Jan; 75(1):523-6. PubMed ID: 17074853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis].
    Azaev MSh; Lebedev LR; Kuz'micheva GA; Tumanov IuV; Donchenko NA; Tat'kov SI; Nosareva OV; Il'ichev AA
    Probl Tuberk Bolezn Legk; 2007; (2):38-42. PubMed ID: 17419334
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell walls.
    Reuben JM; Tanner CE; Portelance V
    Infect Immun; 1979 Mar; 23(3):582-6. PubMed ID: 378829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancement of resistance of mice to tuberculosis by purified components of mycobacterial lipid fractions.
    Anacker RL; Matsumoto J; Ribi E; Smith RF; Yamamoto K
    J Infect Dis; 1973 Apr; 127(4):357-64. PubMed ID: 4632876
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical observations on the use of BCG cell wall fraction for treatment of periocular and other equine sarcoids.
    Owen RA; Jagger DW
    Vet Rec; 1987 Jun; 120(23):548-52. PubMed ID: 3303640
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biology of the mycobacterioses. Simian tuberculosis: immunologic aspects.
    Good RC
    Ann N Y Acad Sci; 1968 Sep; 154(1):200-13. PubMed ID: 4985917
    [No Abstract]   [Full Text] [Related]  

  • 76. Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.
    Kelly MT
    Infect Immun; 1977 Jan; 15(1):180-3. PubMed ID: 319056
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Preferential differentiation of hematopoietic stem cells in mice after intravenous injection of BCG].
    Marchal G
    C R Acad Hebd Seances Acad Sci D; 1976 May; 282(20):1829-32. PubMed ID: 821656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of BCG.
    Sutherland I; Springett VH
    Lancet; 1980 Mar; 1(8166):489. PubMed ID: 6102219
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy of BCG.
    Murtagh K
    Lancet; 1980 Feb; 1(8165):423. PubMed ID: 6101872
    [No Abstract]   [Full Text] [Related]  

  • 80. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
    Kurtz SL; Mittereder LR; Lehman CC; Khan H; Gould VA; Elkins KL
    Infect Immun; 2023 Jul; 91(7):e0016823. PubMed ID: 37338410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.